545 related articles for article (PubMed ID: 8064946)
1. Prevalence of measles antibodies before and after vaccination in previously unvaccinated children of the Cordillera Province (Santa Cruz Department, Bolivia).
Guglielmetti P; Bianchi Bandinelli ML; Bartoloni A; Gamboa H; Roselli M; Valensin PE
J Trop Med Hyg; 1994 Aug; 97(4):231-5. PubMed ID: 8064946
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
[TBL] [Abstract][Full Text] [Related]
3. Seroconversion after measles vaccination at nine and fifteen months of age.
Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
[TBL] [Abstract][Full Text] [Related]
4. Comparison of AIK-C measles vaccine in infants at 6 months with Schwarz vaccine at 9 months: a randomized controlled trial in Ghana.
Nkrumah FK; Osei-Kwasi M; Dunyo SK; Koram KA; Afari EA
Bull World Health Organ; 1998; 76(4):353-9. PubMed ID: 9803586
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
6. Measles antibody titre in children up to 5 years of age in rural areas of Aligarh District, India.
Khan Z; Malik A; Pal SD; Khan MY
Saudi Med J; 2000 Feb; 21(2):175-9. PubMed ID: 11533777
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of measles antibody among children under 15 years of age in Santa Cruz, Bolivia: implications for vaccination strategies.
Cutts FT; Bartoloni A; Guglielmetti P; Gil F; Brown D; Bianchi Bandinelli ML; Roselli M
Trans R Soc Trop Med Hyg; 1995; 89(1):119-22. PubMed ID: 7747295
[TBL] [Abstract][Full Text] [Related]
8. [Seroepidemiology of measles in Mexico].
Sepúlveda J; Tapia-Conyer R; Valdespino JL; Quiroz G; Salvatierra B; Zárate ML; Magos C; Llausás A; Gutiérrez G
Salud Publica Mex; 1992; 34(2):148-56. PubMed ID: 1631729
[TBL] [Abstract][Full Text] [Related]
9. Optimal age for measles vaccination.
Vidyashankar C
J Indian Med Assoc; 2002 Jan; 100(1):24-6. PubMed ID: 12206338
[TBL] [Abstract][Full Text] [Related]
10. Measles vaccination effectiveness among children under 5 years of age in Kampala, Uganda.
Mupere E; Karamagi C; Zirembuzi G; Grabowsky M; de Swart RL; Nanyunja M; Mayanja H
Vaccine; 2006 May; 24(19):4111-5. PubMed ID: 16554111
[TBL] [Abstract][Full Text] [Related]
11. Immune response to measles vaccine after mass vaccination in Urmia, Islamic Republic of Iran.
Yekta Z; Pourali R; Taravati MR; Shahabi S; Salary S; Khalily F; Farzin A
East Mediterr Health J; 2009; 15(3):516-25. PubMed ID: 19731767
[TBL] [Abstract][Full Text] [Related]
12. Measles seroepidemiology among adolescents and young adults: response to revaccination.
Saffar MJ; Alraza-Amiri M; Ajami A; Baba-Mahmoodi F; Khalilian AR; Vahidshahi C; Shamsizadeh A
East Mediterr Health J; 2006 Sep; 12(5):573-81. PubMed ID: 17333796
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing between primary measles infection and vaccine failure reinfection by IgG avidity assay.
Hamkar R; Mahmoodi M; Nategh R; Jelyani KN; Eslami MB; Mohktari-Azad T
East Mediterr Health J; 2006 Nov; 12(6):775-82. PubMed ID: 17333822
[TBL] [Abstract][Full Text] [Related]
14. Predicting and comparing long-term measles antibody profiles of different immunization policies.
Lee MS; Nokes DJ
Bull World Health Organ; 2001; 79(7):615-24. PubMed ID: 11477964
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004.
Yu X; Wang S; Guan J; Mahemuti ; Purhati ; Gou A; Liu Q; Jin X; Ghildyal R
Pediatr Infect Dis J; 2007 Jun; 26(6):513-8. PubMed ID: 17529869
[TBL] [Abstract][Full Text] [Related]
16. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
[TBL] [Abstract][Full Text] [Related]
17. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
[TBL] [Abstract][Full Text] [Related]
18. An outbreak of measles among unvaccinated young adults and measles seroprevalence study: implications for measles outbreak control in adult populations.
Ehresmann KR; Crouch N; Henry PM; Hunt JM; Habedank TL; Bowman R; Moore KA
J Infect Dis; 2004 May; 189 Suppl 1():S104-7. PubMed ID: 15106098
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of measles revaccination among school-entry-aged children.
Watson JC; Pearson JA; Markowitz LE; Baughman AL; Erdman DD; Bellini WJ; Baron RC; Fleming DW
Pediatrics; 1996 May; 97(5):613-8. PubMed ID: 8628596
[TBL] [Abstract][Full Text] [Related]
20. Measles antibody in the children in Ubon Ratchathani province.
Saipan P; Jiwapaisarnpong T; Pattanadilok S; Loyha Y; Janggajit T
J Med Assoc Thai; 2001 Apr; 84(4):500-6. PubMed ID: 11460960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
